Showing results (51-60 of 108) with videos related to
Sort By:
Pageof 11
Cancer Research|February 17, 2017
Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR PathwayMeng Wang, Jing Han, Lynnette Marcar, et al.Science Translational Medicine|May 18, 2018
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastomaTimothy L Lochmann, Krista M Powell, Jungoh Ham, et al.Cancer Cell|January 24, 2018
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing SarcomaAmanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263Anahita Dastur, AHyun Choi, Carlotta Costa, et al.Plos One|July 1, 2024
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination TreatmentAdam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.Plos One|October 14, 2015
Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination TreatmentAdam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.Nature Chemical Biology|October 25, 2019
Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOGLouise Fets, Paul C Driscoll, Fiona Grimm, et al.Nature Chemical Biology|October 10, 2018
MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOGLouise Fets, Paul C Driscoll, Fiona Grimm, et al.Leukemia|May 26, 2019
Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemiaTakenobu Nii, Varun V Prabhu, Vivian Ruvolo, et al.Cancer Discovery|February 23, 2013
Targeting MYCN in neuroblastoma by BET bromodomain inhibitionAlexandre Puissant, Stacey M Frumm, Gabriela Alexe, et al.Pageof 11